• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

DCLK1 在巴雷特食管和食管腺癌患者的血浆中可检测到。

DCLK1 is detectable in plasma of patients with Barrett's esophagus and esophageal adenocarcinoma.

机构信息

Department of Medicine, Digestive Diseases and Nutrition, University of Oklahoma Health Sciences Center, Oklahoma City, OK, 73104, USA.

出版信息

Dig Dis Sci. 2015 Feb;60(2):509-13. doi: 10.1007/s10620-014-3347-4. Epub 2014 Oct 5.

DOI:10.1007/s10620-014-3347-4
PMID:25283374
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8201417/
Abstract

BACKGROUND

Doublecortin-like kinase 1 (DCLK1), a putative tumor stem cell marker has been shown to be highly expressed in the stromal and epithelial compartments in colon and pancreatic cancer as well as Barrett's esophagus (BE) and esophageal adenocarcinoma (EAC).

AIM

To prospectively investigate whether the immunohistochemical expression of DCLK1 was associated with detectable DCLK1 plasma expression in patients with existing BE and EAC.

METHODS

Immunohistochemistry was performed on paraffin-embedded sections using DCLK1 antibody and scored based on staining intensity and tissue involvement. Purified human plasma samples were subjected to Western blot and ELISA analysis.

RESULTS

Forty (40) patients were enrolled: 10 controls (normal endoscopy) and 30 with BE/EAC (13 nondysplastic BE [NDBE], 9 dysplastic BE [DBE] and 8 EAC). Mean epithelial DCLK1 staining was as follows: controls = 0.11, NDBE = 3.83, DBE = 6.0, EAC = 7.17. Mean stromal DCLK1 staining was as follows: NDBE = 5.83, DBE = 5.375, EAC = 10.83. DCLK1 was detected by plasma Western blot in 1 control and in all patients with BE/EAC p < 0.0005. Plasma DCLK1 was elevated by ELISA in EAC compared to other groups, p < 0.05.

CONCLUSIONS

Increased expression of DCLK1 was observed in the epithelium, stroma and plasma of patients with BE/EAC. Furthermore, the presence of detectable DCLK1 in plasma of BE/EAC patients may provide a less invasive, detection tool in those patients as well as represent a novel molecular marker distinguishing between normal esophageal mucosa and BE or EAC.

摘要

背景

双皮质激酶 1(DCLK1),一种假定的肿瘤干细胞标志物,已被证明在结肠癌、胰腺癌以及巴雷特食管(BE)和食管腺癌(EAC)的基质和上皮细胞中高度表达。

目的

前瞻性研究现有的 BE 和 EAC 患者中,DCLK1 的免疫组织化学表达是否与可检测的 DCLK1 血浆表达相关。

方法

使用 DCLK1 抗体对石蜡包埋切片进行免疫组织化学染色,并根据染色强度和组织受累进行评分。纯化的人血浆样本进行 Western blot 和 ELISA 分析。

结果

共纳入 40 例患者:10 例对照(正常内镜)和 30 例 BE/EAC(13 例非异型增生 BE [NDBE]、9 例异型增生 BE [DBE]和 8 例 EAC)。上皮 DCLK1 染色的平均值如下:对照组=0.11,NDBE=3.83,DBE=6.0,EAC=7.17。基质 DCLK1 染色的平均值如下:NDBE=5.83,DBE=5.375,EAC=10.83。在 1 例对照和所有 BE/EAC 患者中,通过血浆 Western blot 检测到 DCLK1,p<0.0005。与其他组相比,EAC 患者的血浆 DCLK1 通过 ELISA 升高,p<0.05。

结论

在 BE/EAC 患者的上皮、基质和血浆中观察到 DCLK1 的表达增加。此外,在 BE/EAC 患者的血浆中检测到可检测的 DCLK1 可能为这些患者提供一种侵入性更小的检测工具,并代表一种区分正常食管黏膜和 BE 或 EAC 的新型分子标志物。

相似文献

1
DCLK1 is detectable in plasma of patients with Barrett's esophagus and esophageal adenocarcinoma.DCLK1 在巴雷特食管和食管腺癌患者的血浆中可检测到。
Dig Dis Sci. 2015 Feb;60(2):509-13. doi: 10.1007/s10620-014-3347-4. Epub 2014 Oct 5.
2
Identification of the putative intestinal stem cell marker doublecortin and CaM kinase-like-1 in Barrett's esophagus and esophageal adenocarcinoma.鉴定巴雷特食管和食管腺癌中的肠干细胞标志物双皮质素和钙调蛋白激酶样-1。
J Gastroenterol Hepatol. 2012 Apr;27(4):773-80. doi: 10.1111/j.1440-1746.2011.06928.x.
3
Neutrophil-Lymphocyte Ratio as a Marker of Progression from Non-Dysplastic Barrett's Esophagus to Esophageal Adenocarcinoma: a Cross-Sectional Retrospective Study.中性粒细胞与淋巴细胞比值作为非异型增生 Barrett 食管进展为食管腺癌的标志物:一项横断面回顾性研究。
J Gastrointest Surg. 2020 Jan;24(1):8-18. doi: 10.1007/s11605-019-04456-x. Epub 2019 Nov 19.
4
Genetic profiles of Barrett's esophagus and esophageal adenocarcinoma in Japanese patients.日本患者 Barrett 食管和食管腺癌的遗传特征。
Sci Rep. 2021 Sep 3;11(1):17671. doi: 10.1038/s41598-021-97249-9.
5
Expression profiles of cancer stem cell markers: CD133, CD44, Musashi-1 and EpCAM in the cardiac mucosa-Barrett's esophagus-early esophageal adenocarcinoma-advanced esophageal adenocarcinoma sequence.癌症干细胞标志物:CD133、CD44、Musashi-1和EpCAM在贲门黏膜-巴雷特食管-早期食管腺癌-进展期食管腺癌序列中的表达谱。
Pathol Res Pract. 2017 Mar;213(3):205-209. doi: 10.1016/j.prp.2016.12.018. Epub 2016 Dec 30.
6
Elevated doublecortin-like kinase 1 serum levels revert to baseline after therapy in early stage esophageal adenocarcinoma.在早期食管腺癌患者接受治疗后,其血清中双皮质素样激酶1水平升高的情况会恢复至基线水平。
Biomark Res. 2019 Mar 8;7:5. doi: 10.1186/s40364-019-0157-z. eCollection 2019.
7
Doublecortin-like kinase 1 is elevated serologically in pancreatic ductal adenocarcinoma and widely expressed on circulating tumor cells.双皮质素样激酶1在胰腺导管腺癌中血清学水平升高,并在循环肿瘤细胞上广泛表达。
PLoS One. 2015 Feb 27;10(2):e0118933. doi: 10.1371/journal.pone.0118933. eCollection 2015.
8
Nanoscale markers of esophageal field carcinogenesis: potential implications for esophageal cancer screening.食管区域癌变的纳米级标志物:对食管癌筛查的潜在影响。
Endoscopy. 2013 Dec;45(12):983-8. doi: 10.1055/s-0033-1344617. Epub 2013 Sep 9.
9
Minichromosomal Maintenance Component Complex 5 (MCM5) as a Marker of Barrett's Esophagus-Related Neoplasia: A Feasibility Study.MCM5 作为 Barrett 食管相关肿瘤标志物的可行性研究。
Dig Dis Sci. 2019 Oct;64(10):2815-2822. doi: 10.1007/s10620-019-05607-5. Epub 2019 Apr 13.
10
Goblet Cell Ratio in Combination with Differentiation and Stem Cell Markers in Barrett Esophagus Allow Distinction of Patients with and without Esophageal Adenocarcinoma.杯状细胞比例联合巴雷特食管的分化和干细胞标志物可区分有无食管腺癌的患者。
Cancer Prev Res (Phila). 2017 Jan;10(1):55-66. doi: 10.1158/1940-6207.CAPR-16-0117. Epub 2016 Nov 2.

引用本文的文献

1
From Inflammation to Oncogenesis: Tracing Serum DCLK1 and miRNA Signatures in Chronic Liver Diseases.从炎症到肿瘤发生:在慢性肝脏疾病中追踪血清 DCLK1 和 miRNA 特征。
Int J Mol Sci. 2024 Jun 12;25(12):6481. doi: 10.3390/ijms25126481.
2
Augmented CPT1A Expression Is Associated with Proliferation and Colony Formation during Barrett's Tumorigenesis.增强的 CPT1A 表达与 Barrett 肿瘤发生过程中的增殖和集落形成有关。
Int J Mol Sci. 2022 Oct 4;23(19):11745. doi: 10.3390/ijms231911745.
3
DCLK1 and its interaction partners: An effective therapeutic target for colorectal cancer.

本文引用的文献

1
XMD8-92 inhibits pancreatic tumor xenograft growth via a DCLK1-dependent mechanism.XMD8-92 通过依赖于 DCLK1 的机制抑制胰腺肿瘤异种移植物生长。
Cancer Lett. 2014 Aug 28;351(1):151-61. doi: 10.1016/j.canlet.2014.05.011. Epub 2014 May 28.
2
DCLK1 regulates pluripotency and angiogenic factors via microRNA-dependent mechanisms in pancreatic cancer.DCLK1 通过 microRNA 依赖的机制调节胰腺癌中的多能性和血管生成因子。
PLoS One. 2013 Sep 9;8(9):e73940. doi: 10.1371/journal.pone.0073940. eCollection 2013.
3
Trends in esophageal adenocarcinoma incidence and mortality.
双皮质素样激酶1(DCLK1)及其相互作用蛋白:结直肠癌的有效治疗靶点。
Oncol Lett. 2021 Dec;22(6):850. doi: 10.3892/ol.2021.13111. Epub 2021 Oct 26.
4
Comprehensive Analysis and Identification of Key Driver Genes for Distinguishing Between Esophageal Adenocarcinoma and Squamous Cell Carcinoma.鉴别食管腺癌和鳞状细胞癌关键驱动基因的综合分析与鉴定
Front Cell Dev Biol. 2021 May 28;9:676156. doi: 10.3389/fcell.2021.676156. eCollection 2021.
5
Pediatric Patient With Concurrent Eosinophilic Esophagitis, Erosive Reflux Esophagitis, and Barrett's Esophagus.患有嗜酸性粒细胞性食管炎、糜烂性反流性食管炎和巴雷特食管的儿科患者。
ACG Case Rep J. 2020 Jun 24;7(6):e00399. doi: 10.14309/crj.0000000000000399. eCollection 2020 Jun.
6
DCLK1, a Putative Stem Cell Marker in Human Cholangiocarcinoma.DCLK1,人胆管癌中的一个假定干细胞标志物。
Hepatology. 2021 Jan;73(1):144-159. doi: 10.1002/hep.31571.
7
Chemical Biology Toolkit for DCLK1 Reveals Connection to RNA Processing.DCLK1 的化学生物学工具包揭示了与 RNA 处理的关联。
Cell Chem Biol. 2020 Oct 15;27(10):1229-1240.e4. doi: 10.1016/j.chembiol.2020.07.011. Epub 2020 Aug 4.
8
The prognostic value of leucine-rich repeat-containing G-protein (Lgr5) and its impact on clinicopathological features of colorectal cancer.富含亮氨酸重复序列的 G 蛋白(Lgr5)的预后价值及其对结直肠癌临床病理特征的影响。
J Cancer Res Clin Oncol. 2020 Oct;146(10):2547-2557. doi: 10.1007/s00432-020-03314-7. Epub 2020 Jul 15.
9
Cancer Stem Cell Marker DCLK1 Correlates with Tumorigenic Immune Infiltrates in the Colon and Gastric Adenocarcinoma Microenvironments.癌症干细胞标志物DCLK1与结肠和胃腺癌微环境中的致瘤性免疫浸润相关。
Cancers (Basel). 2020 Jan 22;12(2):274. doi: 10.3390/cancers12020274.
10
Doublecotin-Like Kinase 1 Increases Chemoresistance of Colorectal Cancer Cells through the Anti-Apoptosis Pathway.双皮质素样激酶1通过抗凋亡途径增加结肠癌细胞的化疗耐药性。
J Stem Cell Res Ther. 2019;9(3). doi: 10.4172/2157-7633.1000447. Epub 2019 May 3.
食管腺癌发病率和死亡率的趋势。
Cancer. 2013 Mar 15;119(6):1149-58. doi: 10.1002/cncr.27834. Epub 2012 Dec 11.
4
Barrett's esophagus and adenocarcinoma risk: the experience of the North-Eastern Italian Registry (EBRA).巴雷特食管和腺癌风险:意大利东北部注册研究(EBRA)的经验。
Ann Surg. 2012 Nov;256(5):788-94; discussion 794-5. doi: 10.1097/SLA.0b013e3182737a7e.
5
Bile acid and inflammation activate gastric cardia stem cells in a mouse model of Barrett-like metaplasia.胆汁酸和炎症激活了巴雷特样化生小鼠模型中的胃贲门干细胞。
Cancer Cell. 2012 Jan 17;21(1):36-51. doi: 10.1016/j.ccr.2011.12.004.
6
Nanoparticle-based delivery of siDCAMKL-1 increases microRNA-144 and inhibits colorectal cancer tumor growth via a Notch-1 dependent mechanism.基于纳米颗粒的 siDCAMKL-1 递呈通过 Notch-1 依赖机制增加 microRNA-144 并抑制结直肠癌细胞生长。
J Nanobiotechnology. 2011 Sep 19;9:40. doi: 10.1186/1477-3155-9-40.
7
Identification of the putative intestinal stem cell marker doublecortin and CaM kinase-like-1 in Barrett's esophagus and esophageal adenocarcinoma.鉴定巴雷特食管和食管腺癌中的肠干细胞标志物双皮质素和钙调蛋白激酶样-1。
J Gastroenterol Hepatol. 2012 Apr;27(4):773-80. doi: 10.1111/j.1440-1746.2011.06928.x.
8
Risk factors for progression of low-grade dysplasia in patients with Barrett's esophagus.巴雷特食管患者低级别上皮内瘤变进展的危险因素。
Gastroenterology. 2011 Oct;141(4):1179-86, 1186.e1. doi: 10.1053/j.gastro.2011.06.055. Epub 2011 Jun 30.
9
Risk of malignant progression in Barrett's esophagus patients: results from a large population-based study.巴雷特食管患者恶性进展的风险:一项大型基于人群的研究结果。
J Natl Cancer Inst. 2011 Jul 6;103(13):1049-57. doi: 10.1093/jnci/djr203. Epub 2011 Jun 16.
10
IFN-γ inhibits gastric carcinogenesis by inducing epithelial cell autophagy and T-cell apoptosis.IFN-γ 通过诱导上皮细胞自噬和 T 细胞凋亡抑制胃癌的发生。
Cancer Res. 2011 Jun 15;71(12):4247-59. doi: 10.1158/0008-5472.CAN-10-4009. Epub 2011 Apr 21.